|
|
|
|
| LEADER |
01000caa a22002652c 4500 |
| 001 |
NLM333256107 |
| 003 |
DE-627 |
| 005 |
20250302164656.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
231225s2022 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1002/adma.202107820
|2 doi
|
| 028 |
5 |
2 |
|a pubmed25n1110.xml
|
| 035 |
|
|
|a (DE-627)NLM333256107
|
| 035 |
|
|
|a (NLM)34787933
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Zhang, Tao
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Functionalizing Framework Nucleic-Acid-Based Nanostructures for Biomedical Application
|
| 264 |
|
1 |
|c 2022
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 21.11.2022
|
| 500 |
|
|
|a Date Revised 21.11.2022
|
| 500 |
|
|
|a published: Print-Electronic
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a © 2022 Wiley-VCH GmbH.
|
| 520 |
|
|
|a Strategies for functionalizing diverse tetrahedral framework nucleic acids (tFNAs) have been extensively explored since the first successful fabrication of tFNA by Turberfield. One-pot annealing of at least four DNA single strands is the most common method to prepare tFNA, as it optimizes the cost, yield, and speed of assembly. Herein, the focus is on four key merits of tFNAs and their potential for biomedical applications. The natural ability of tFNA to scavenge reactive oxygen species, along with remarkable enhancement in cellular endocytosis and tissue permeability based on its appropriate size and geometry, promotes cell-material interactions to direct or probe cell behavior, especially to treat inflammatory and degenerative diseases. Moreover, the structural programmability of tFNA enables the development of static tFNA-based nanomaterials via engineering of functional oligonucleotides or therapeutic molecules, and dynamic tFNAs via attachment of stimuli-responsive DNA apparatuses, leading to potential applications in targeted therapies, tissue regeneration, antitumor strategies, and antibacterial treatment. Although there are impressive performance and significant progress, the challenges and prospects of functionalizing tFNA-based nanostructures are still indicated in this review
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a Review
|
| 650 |
|
4 |
|a ROS scavenging
|
| 650 |
|
4 |
|a antibacterial therapy
|
| 650 |
|
4 |
|a anticancer therapy
|
| 650 |
|
4 |
|a drug delivery
|
| 650 |
|
4 |
|a dynamic DNA structure
|
| 650 |
|
4 |
|a tetrahedral framework nucleic acids
|
| 650 |
|
4 |
|a tissue engineering
|
| 650 |
|
7 |
|a Nucleic Acids
|2 NLM
|
| 650 |
|
7 |
|a DNA
|2 NLM
|
| 650 |
|
7 |
|a 9007-49-2
|2 NLM
|
| 650 |
|
7 |
|a DNA, Single-Stranded
|2 NLM
|
| 650 |
|
7 |
|a Oligonucleotides
|2 NLM
|
| 700 |
1 |
|
|a Tian, Taoran
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Lin, Yunfeng
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Advanced materials (Deerfield Beach, Fla.)
|d 1998
|g 34(2022), 46 vom: 15. Nov., Seite e2107820
|w (DE-627)NLM098206397
|x 1521-4095
|7 nnas
|
| 773 |
1 |
8 |
|g volume:34
|g year:2022
|g number:46
|g day:15
|g month:11
|g pages:e2107820
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1002/adma.202107820
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 34
|j 2022
|e 46
|b 15
|c 11
|h e2107820
|